FYARRO: payments to doctors
Payments that named FYARRO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $993K
- Providers
- 1,525
- Transactions
- 2,560
- Average per transaction
- $388
The per-transaction average — $388 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,525 providers the average total is $651, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Aadi Bioscience, Inc. | $806,447 | 81.2% |
| Fennec Pharmaceuticals, Inc. | $186,488 | 18.8% |